Entrada Therapeutics (TRDA) Asset Utilization Ratio (2023 - 2025)
Entrada Therapeutics (TRDA) has 3 years of Asset Utilization Ratio data on record, last reported at 0.06 in Q4 2025.
- For Q4 2025, Asset Utilization Ratio fell 83.5% year-over-year to 0.06; the TTM value through Dec 2025 reached 0.06, down 83.5%, while the annual FY2025 figure was 0.06, 86.71% down from the prior year.
- Asset Utilization Ratio reached 0.06 in Q4 2025 per TRDA's latest filing, down from 0.14 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.44 in Q2 2024 and bottomed at 0.06 in Q4 2025.
- Average Asset Utilization Ratio over 3 years is 0.24, with a median of 0.22 recorded in 2023.
- Peak YoY movement for Asset Utilization Ratio: surged 389.05% in 2024, then crashed 83.5% in 2025.
- A 3-year view of Asset Utilization Ratio shows it stood at 0.27 in 2023, then skyrocketed by 44.23% to 0.39 in 2024, then plummeted by 83.5% to 0.06 in 2025.
- Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.06 in Q4 2025, 0.14 in Q3 2025, and 0.17 in Q2 2025.